background image

 
1

 

 

Fifth stage 

Neuro-Surgery

 

Lec-2 

د. عبدالرحمن 

2/5/2016 

 

Cerebral Edema 

 and 

Increased Intracranial Pressure  

(Intracranial Hypertension) 

 

Cerebral Oedema:  

Classification: 

1.  Vasogenic Oedema  

2.  Cytotoxic Oedema  

3.  Osmotic Cerebral Oedema  

4.  Hydrostatic Cerebral Oedema  

 

Vasogenic Oedema: 

  is the most common form of brain oedema encountered in clinical practice.  
  This type is due to increased permeability of cerebral capillaries with resultant 

accumulation of plasma or its filtrate to enter the extracellular space of the brain. This 
type is seen commonly in trauma, primary and metastatic tumours and focal 
inflammation like brain abscess. 

 

Cytotoxic Oedema: 

  Derangement of cellular metabolism which result in inadequate functioning of the 

sodium and potassium pump leading to cellular retention of sodium and water and cell 
swelling. 

   This type is seen in various intoxications (e.g., dinitrophenol), Reye’s syndrome and 

sever hypothermia. 

 

 

 


background image

 
2

 

 

Osmotic Cerebral Oedema: 

  Accumulation of excess water in the brain in response to an unfavorable osmotic 

gradient operating across the intact Blood Brain Barrier (BBB).  

  This type is seen in : 

   1. Pathologic ingestion of water. 

   2. Inappropriate secretion of antidiuretic hormone. 

   3. Sever haemodialysis of the uraemic patient. 

 

Hydrostatic Cerebral Oedema: 

  Occurs in acute hypertension in which the elevated pressure is directly transmitted to 

the cerebral capillaries. 

 

 

Increased Intracranial Pressure (Intracranial Hypertension)

 

 

Pathophysiology: 

 The adult skull: 

1.  Brain. 

2.  Cerebrospinal Fluid (CSF). 

3.  Blood. 

 

  The normal supine intracranial pressure is 5-15 mmHg (60-180 mmH2O). 
  An increase in the volume of any one of the contents of the skull will result in an 

increase in the intracranial pressure (ICP). 

  The brains ability to compensate for raised ICP is rapidly exhausted. 
  Raised ICP is dangerous to the brain. 

 

Etiology: 

1.  Localized masses like:  

•  Haematomas: epidural, subdural, and intracerebral. 


background image

 
3

 

 

•  Neoplasms: gliomas, meningiomas, and metastases. 

•  Abscesses (brain abscesses). 

•  Focal oedema due to traumas, infection, and tumours. 

2. Obstruction to CSF pathways: as seen in: 

•  Obstructive hydrocephalus. 

•  Communicating hydrocephalus. 

3. Obstruction to major venous sinuses as a result of: 

•  Depressed skull fracture over major venous sinuses. 

•  Thromboembolic disease from contraceptive pills. 

4. Diffuse brain oedema or swelling:   

•  due to encephalitis, meningitis, diffuse head injury, subarachnoid haemorrhage, 

Reye's syndrome, water intoxication from fluid overload. 

5. Idiopathic intracranial hypertension is a disease most commonly found in adult female 
patients (also called pseudotumour cerebri). 

6. Systemic hypertension can cause breakdown of the blood brain barrier and causes 
hypertensive encephalopathy. 

7. Cerebral Herniation: 

•  Subfalcine Herniation 

•  Uncal Herniation 

•  Tentorial Herniation 

•  Tonsillar Herniation 

 

 

Clinical Features: 

1.  Without symptoms and signs. 

2.  Headache. 

3.  Nausea and vomiting. 

4.  Drowsiness or altered mental status. 

5.  Papilloedema 

6.  Sixth nerve palsy (False localizing sign). 


background image

 
4

 

 

7.  At later stages the triad of bradycardia, hypertension and respiratory irregularities. 

8.  In infants: tense bulging fontanelle. 

 

Skull X-ray findings in increased intracranial pressure: 

1.  Sutural separation in children. 

2.  ‘Copper-beating’ marking of the cranial vault. 

3.  Thinning of dorsum sellae. 

4.  Erosion of the posterior clinoid process. 

 

Treatment of Intracranial Hypertension

1.  Head position (Head elevation). 

2.  Hyperventilation: PCO

2

 down to (30-34 mmHg). 

3.  Hypertonic solutions including: 

•  Mannitol, dose of 1g/kg 

•  Hypertonic saline. 

4.  Furosemide (Loop diuretic): act by 

•  Reducing cerebral oedema. 

•  Reduce CSF production. 

•  Act synergistically with mannitol. 

5.  Steroids (dexamethasone 4mg, 6-hourly).  

•  Stabilizing the blood brain barrier (BBB). 

•  Reducing oxygen free radicals. 

6.  Ventricular drainage. 

7.  Barbiturates: reducing cerebral metabolism. 

8.  Hypothermia down to 34°C is a brain protective agent. 

9.  Surgical intervention.  

 




رفعت المحاضرة من قبل: Abdalmalik Abdullateef
المشاهدات: لقد قام 13 عضواً و 188 زائراً بقراءة هذه المحاضرة








تسجيل دخول

أو
عبر الحساب الاعتيادي
الرجاء كتابة البريد الالكتروني بشكل صحيح
الرجاء كتابة كلمة المرور
لست عضواً في موقع محاضراتي؟
اضغط هنا للتسجيل